Profile
Dr. Ivo Staijen is a Head Public Equity & Portfolio Manager at HBM Partners AG.
He has over 15 years of experience in the pharma industry and investment analysis and portfolio management.
He was previously a Senior Biotechnology Analyst at Bank Sarasin and Department Head at MDS Pharma Services.
He holds a Ph.D.
in biotechnology from ETH Zurich and an M.Sc.
in chemistry from the University of Groningen.
Ivo Staijen active positions
| Companies | Position | Start |
|---|---|---|
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Head-Equity Investments | 01/04/2003 |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Private Equity Investor | 01/04/2003 |
Former positions of Ivo Staijen
| Companies | Position | End |
|---|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Director/Board Member | 03/10/2012 |
Bank Sarasin & Cie AG (Broker)
Bank Sarasin & Cie AG (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 06/02/2003 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Health Technology |
Bank Sarasin & Cie AG (Broker)
Bank Sarasin & Cie AG (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Finance |
- Stock Market
- Insiders
- Ivo Staijen
















